AP
IPXL

AHL Partners’s Impax Laboratories, Inc. IPXL Stock Holding History

AHL Partners’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-113,238
Closed -$1.43M – 1295
2017
Q1 		$1.43M Buy
113,238
+85,727
+312% +$1.04M 0.03% 700
2016
Q4 		$365K Buy
+27,511
New +$470K 0.01% 930
2015
Q3 		– Sell
-55,814
Closed -$2.56M – 862
2015
Q2 		$2.56M Sell
55,814
-10,668
-16% -$506K 0.1% 425
2015
Q1 		$3.12M Buy
66,482
+12,053
+22% +$480K 0.12% 401
2014
Q4 		$1.72M Buy
+54,429
New +$1.59M 0.09% 496

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AHL Partners's IPXL Position: Q2 2017 in Review

AHL Partners sold out of Impax Laboratories, Inc. (IPXL) in Q2 2017, closing a stake of 113,238 shares — an estimated $1.43M sold.

AHL Partners first reported a position in IPXL in Q4 2014 and held it in 5 quarters. The position peaked at $3.12M in Q1 2015. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.

  • AHL Partners reported no remaining Impax Laboratories, Inc. position as of Q2 2017 after selling out during the quarter.
  • AHL Partners sold 113,238 Impax Laboratories, Inc. shares in Q2 2017, an estimated $1.43M.
  • AHL Partners first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 5 quarters.
  • AHL Partners's Impax Laboratories, Inc. position peaked at $3.12M in Q1 2015.
  • 172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.

Based on AHL Partners's 13F filing for Q2 2017, filed 14 Aug 2017.